Quest Capital Management, Inc . is the famous VC, which was founded in 1987. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Dallas.
Among the most popular fund investment industries, there are Hardware, Medical. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Roche Glycart, Anadigm, Cyclacel Pharmaceuticals For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups.
We also calculated 2 valuable employees in our database.
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Quest Capital Management, Inc ., startups are often financed by Scottish Equity Partners, Quester Capital, 3i Group. The meaningful sponsors for the fund in investment in the same round are NIF Ventures, UOB Venture, Temasek Holdings. In the next rounds fund is usually obtained by Scottish Equity Partners.
The usual things for fund are deals in the range of 10 - 50 millions dollars. This Quest Capital Management, Inc . works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2006. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2003.
Related Funds
Fund Name | Location |
Algo Capital | Boston, Massachusetts, United States |
Camros Capital | Boston, Massachusetts, United States |
Corporation Ventures | Buenaventura, Colombia, Valle del Cauca |
Gedoumi.com | - |
Koor Corporate Venture Capital | Israel, Tel Aviv, Tel Aviv District |
Rallyday Partners | Colorado, Denver, United States |
Sammons Financial | Iowa, United States, West Des Moines |
Virtus Inspire Ventures | China, Hong Kong, Hong Kong Island |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Roche Glycart | $13M | 26 Nov 2003 | Zurich, Switzerland | ||
Anadigm | $15M | 02 Oct 2003 | Mesa, Arizona, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Roche Glycart | $13M | 26 Nov 2003 | Zurich, Switzerland | ||
Anadigm | $15M | 02 Oct 2003 | Mesa, Arizona, United States |